Trial Dims Prospects for Rivaroxaban's Cardiovascular Protection in Advanced CKD

(MedPage Today) -- An established blood thinner regimen failed to extend its cardioprotective benefits to patients with advanced chronic kidney disease (CKD), according to the international TRACK trial.
In this placebo-controlled study of patients...